MST1 and neoplasm: In hepatocellular carcinoma,[19, 20, 21, 22] colon cancer,[23, 24] lung cancer,[24, 25] breast cancer[26] and glioma,[27] downregulation of MST1/2 is associated with accelerated tumor progression.